{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T10:40:21Z","timestamp":1778236821627,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.heliyon.2024.e29606","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T10:28:18Z","timestamp":1713176898000},"page":"e29606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7217-7900","authenticated-orcid":false,"given":"Yahdiana","family":"Harahap","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salsabila","family":"Salsabila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Febrina Amelia","family":"Saputri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.heliyon.2024.e29606_bib1","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1039\/C8AY00828K","article-title":"Development and validation of a LC-MS\/MS method for ivermectin quantification in dried blood spots: application to a pharmacokinetic study in: trichuris trichiura -infected adults","volume":"10","author":"Schulz","year":"2018","journal-title":"Anal. Methods"},{"issue":"9112","key":"10.1016\/j.heliyon.2024.e29606_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(97)12450-3","article-title":"Onchocerciasis","volume":"351","author":"Burnham","year":"1998","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29606_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007407","article-title":"From River blindness to river epilepsy: implications for onchocerciasis elimination programmes","volume":"13","author":"Colebunders","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e29606_bib4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4269\/ajtmh.20-0271","article-title":"Ivermectin and COVID-19: keeping rigor in times of urgency","volume":"102","author":"Chaccour","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29606_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008965","article-title":"Onchocerca volvulus and epilepsy: a comprehensive review using the bradford hill criteria for causation","volume":"15","author":"Colebunders","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.heliyon.2024.e29606_bib6","first-page":"81","article-title":"Onchocerciasis elimination: progress and challenges","volume":"11","author":"Lakwo","year":"2020","journal-title":"Res. Rep. Trop. Med."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e29606_bib7","first-page":"1645","article-title":"Ivermectin for prophylaxis and treatment of COVID-19: a systematic review and meta-analysis","volume":"11","author":"Cruciani","year":"2021","journal-title":"Diagnostics 2021"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29606_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.712","article-title":"Identification of the metabolites of ivermectin in humans","volume":"9","author":"Tipthara","year":"2021","journal-title":"Pharmacology Research & Perspectives"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e29606_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1208\/s12248-007-9000-9","article-title":"The pharmacokinetics and interactions of ivermectin in humans - a mini-review","volume":"10","author":"Canga","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.heliyon.2024.e29606_bib10","first-page":"384","article-title":"Can ivermectin mass treatments eliminate onchocerciasis in Africa?","volume":"80","author":"Winnen","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.heliyon.2024.e29606_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3329\/jbcps.v38i0.47512","article-title":"A case series of 100 COVID-19 positive patients treated with combination of ivermectin and doxycycline","author":"Alam","year":"2020","journal-title":"J. Bangladesh Coll. Phys. Surg."},{"key":"10.1016\/j.heliyon.2024.e29606_bib12","first-page":"1332","volume":"297","author":"Caly","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e29606_bib13","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/ced.14704","article-title":"Ivermectin in dermatology: why it \u2018mite\u2019 Be useless against COVID-19","volume":"46","author":"Roche","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29606_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5455\/2319-2003.ijbcp002712","article-title":"IJBCP international journal of basic & clinical pharmacology ivermectin: pharmacology and therapeutic applications","volume":"|1","author":"Chhaiya","year":"2012","journal-title":"Int. J. Basic Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29606_bib15","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4103\/idoj.idoj_298_21","article-title":"Current use of ivermectin in dermatology, tropical medicine, and COVID-19: an update on pharmacology, uses, proven and varied proposed mechanistic action","volume":"12","author":"Mathachan","year":"2021","journal-title":"Indian Dermatology Online Journal"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e29606_bib16","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/cpt.1889","article-title":"The approved dose of ivermectin alone is not the ideal dose for the treatment of COVID-19","volume":"108","author":"Schmith","year":"2020","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e29606_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001350","article-title":"Ivermectin may Be a clinically useful anti-inflammatory agent for late-stage COVID-19","volume":"7","author":"Dinicolantonio","year":"2020","journal-title":"Open Heart"},{"issue":"10","key":"10.1016\/j.heliyon.2024.e29606_bib19","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1515\/cclm-2020-0022","article-title":"Blood sampling for metanephrines comparing venipuncture vs. Indwelling intravenous cannula in healthy subjects","volume":"58","author":"Eijkelenkamp","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.heliyon.2024.e29606_bib20","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.2147\/DDDT.S278892","article-title":"Volumetric absorptive microsampling as a sampling alternative in clinical trials and therapeutic drug monitoring during the COVID-19 pandemic: a review","volume":"14","author":"Harahap","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.heliyon.2024.e29606_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113102","article-title":"Opportunities and obstacles for microsampling techniques in bioanalysis: special focus on DBS and VAMS","volume":"182","author":"Londhe","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e29606_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jpba.2016.12.012","article-title":"Volumetric absorptive microsampling (VAMS) as an alternative to conventional dried blood spots in the quantification of miltefosine in dried blood samples","volume":"135","author":"Kip","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e29606_bib23","author":"El"},{"key":"10.1016\/j.heliyon.2024.e29606_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113597","article-title":"Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: usefulness, benefits and pitfalls","volume":"191","author":"Protti","year":"2020","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e29606_bib25","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jpba.2017.05.050","article-title":"Application of volumetric absorptive microsampling device for quantification of tacrolimus in human blood as a model drug of high blood cell partition","volume":"143","author":"Kita","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e29606_bib26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jpba.2017.03.047","article-title":"Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients","volume":"140","author":"Qu","year":"2017","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e29606_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpba.2019.04.007","article-title":"Development and validation of an LC-MS\/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system","volume":"172","author":"Duthaler","year":"2019","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.heliyon.2024.e29606_bib28","first-page":"1","volume":"vol. 44","year":"2011"},{"key":"10.1016\/j.heliyon.2024.e29606_bib29","first-page":"1","article-title":"Bioanalytical method validation guidance for industry","year":"2018","journal-title":"Revista Romana de Medicina de Laborator (May)"},{"issue":"12","key":"10.1016\/j.heliyon.2024.e29606_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-4632.2004.02253.x","article-title":"Ivermectin: pharmacology and application in dermatology","volume":"44","author":"Dourmishev","year":"2005","journal-title":"Int. J. Dermatol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e29606_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bcp.13840","article-title":"Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers","volume":"85","author":"Duthaler","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e29606_bib32","first-page":"1","article-title":"UHPLC method development","volume":"2013","author":"Chen","year":"2013","journal-title":"Ultra-High Performance Liquid Chromatography and its Applications"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e29606_bib33","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/molecules25133047","article-title":"Compenstate for or minimize matrix effects? Startegies for overcoming matrix effects in liquid chromatography-mass spectrometry technique: a tutorial review","volume":"25","author":"Cortese","year":"2020","journal-title":"Molecules"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024056378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024056378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:40:54Z","timestamp":1773765654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024056378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2405844024056378"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29606","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e29606"}}